Difficulties in Irritable Bowel Syndrome: Disease Definition, Epidemiology, Pain Management and Treatment

Document Type : Review Article


Department of Gastroenterology, Nuffield Hospital, Leicester, LE5 5HY UK


The diagnosis and definition of irritable bowel syndrome is problematic. However, its existence as a disease entity has been recognised for at least a thousand years with both Rhazes and ibn Sina discussing the constellation of symptoms which make up thye syndrome. In recent times attention has focused on which symptoms and their duration are critical to the diagnosis. This work has been encapsulated in the reports of the Rome Foundation. The difficulties in disease definition have led to wide variations between reports on the condition’s prevalence in both within and between countries. Nevertheless, it is clear that irritable bowel syndrome is common across all societies. It is consequently of concern that allopathic medications are of limited benefit, particularly in the management of pain, and this has generated a growing interest in traditional therapies as well as hypnotherapy and acupuncture. This review touches on these issues and will hopefully stimulate further research.


  1. Mitra D, Davis KL & Baran RW (2011) All-cause health care charges among managed care patients with constipation and co-morbid irritable bowel syndrome. Postgraduate Medicine 123: pp 122 – 132.
  2. Powell R (1820) On certain painful affections of the intestinal canal. Medical Transactions of the Royal College of Physicians 6: pp 106 – 107.
  3. Naseri M, Babaeian M, Ghaffari F, Kamalinejad M, Feizi A, Mazaheri M et al (2016) Bloating: Avicenna’s perspective and modern medicine Journal of Evidence-Based Complementary & Alternative Medicine 121(2): pp 154-159.
  4. Mosleh G, Mohagheghzadeh A, Hamedi A, Salehi M & Hosseini SMK (2013) Irritable Bowel Syndrome Pathophysiology According to Traditional Iranian Medicine https:// ibimapublishing.com /ar ticles/ ENDO/2016/688997/688997.pdf (Accessed 14/2/2022).
  5. Peters GA & Bargen JA (1944) The irritable bowel syndrome. Gastroenterology 3: pp 399 -402.
  6.  Brown PW (1947) The irritable bowel syndrome Journal of the Kansas Medical Society 48(7): pp 309 – 312.
  7. Chumpitazi BP & Shulman RJ (2016) Underlying molecular and cellular mechanisms inn childhood irritable bowel syndrome. Molecular and Cellular Pediatrics 3(1): p 11.
  8.  Quigley EMM (2018) The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS) Journal of Clinical Medicine 7: 6; doi:10.3390/jcm7010006.
  9.  El-Sahy M, Hatlebakk JG, Gilja OH, Ktistoffersen AB & Hausken T (2020) Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double=blind, placebo=controlled study. Gut 69: pp. 859 - 867.
  10.  Manning AP, Thompson WG, Heaton KW & Morris AF (1978) Towards positive diagnosis of the irritable bowel. British Medical Journal 2(6138): pp 653 – 654.
  11. Drossman DA (2016) Rome IV. Functional Gastrointestinal Disorders. Disorders of Gut-Brain Interaction. 4th E dition Rome Foundation Raleigh.
  12.  Mujagic Z., Keszthelyi D, Aziz Q, Reinsisch W, Quetglas EG, De Leonardis F et al (2015) Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 42: pp 1064 – 1081.
  13.  Simren M, Mansson A, Langkilde AM, Svedlund J, Abrahamsson H, Bengtsson U et al (2001) Digestion 63 (2): pp 108 – 115.
  14.  Patel A, Hasak S, Cassell B, Cioba MA, Vivio EE, Kumar M et al (2016) Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in IBS. Alimentary Pharmacology & Therapeutics 44(3): pp 246 – 258.
  15.  Buchanan DT, Cain K, Heitkemper M, Burr R, Vitiello MV, Zia J et al (2014) Sleep measures predict next-day symptoms in women with irritable bowel syndrome. Journal of Clinical Sleep Medicine 10(9): pp 1003 – 1009.
  16.  Hong-Yan Q, Chung-Wah C, Xu-Dong & Bhian ZX (2014) Impact of psychological stress on irritable bowel syndrome. World Journal of Gastroenterology 20(39): pp 14126– 14131.
  17.  Fond G, Loundou A, Hamdani N, Boukouaci W, Dargel A, Oliveira J et al (2014) A nxiety and depression comorbidities in irritable bowel syndrome(IBS): a systematic review and meta-analysis. European Archives of Psychiatry & Clinical Neuroscience 264(8): pp 651 – 660.
  18.  Hillila MT & Farkkila MA (2004) Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Alimentary Pharmacology & Therapeutics 20(3): pp 339 - 345.
  19.  Anand AC, Saiprasad GS & Bhalwar R (1998) A search for unhappy abdomen: prevalence of irritable bowel syndrome in general population. Medical Journal, Armed Forces India 54(2): pp 123 - 127.
  20.  Waehrens R, Ohlsson H, Sundquist J, Sundquist K & Zoller B (2013) Low prevalence of irritable bowel syndrome in primary health care in four Swedish counties. Scandinavian Journal of Primary Health Care 31(3): pp 132 – 137.
  21.  Zuckerman MJ, Schmulson MJ, Bashashati M, Jia Y, Dwivedi A, Ortiz M et al (2018) Irritable bowel syndrome on the US Mexico Border: A survey in an indigent population using Rome III criteria. Journal of Clinical Gastroenterology 52(7): pp 622 – 627.
  22.  Lovell RM & Ford AC (2012) Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. American Journal of Gastroenterology 107(7): pp 991– 1000.
  23.  Pan C-H, Chang C-C, Su C-T & Tsai P-S (2016) Trends in irritable bowel syndrome incidence among Taiwanese adults during 2003 – 2013: a population based study of sex anad age differences. PLoS 11(11): e0166922. doi: 10.1371/journal.
  24. pone.016692224. Talley NJ, Zinsmeister AR & Melton LJ (1995) Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. American Journal of Epidemiology 142(1): pp 76 - 83.
  25.  Krogsgaard LR, Engsbro AL, Jones MP & Bytzer P (2017) The epidemiology of irritable bowel syndrome: Symptom development over a 3-year period in Denmark. A prospective, population-based cohort. Neurogastroenterology & Motility 29(4): doi: 10.1111/nmo.12986. Epub 2016 Nov 14.
  26.  Schauer B, Grabe HJ, Itterman T, Lerch MM, Weiss FU, Mőnnikes H et al (2019) Irritable bowel syndrome, mental health, and quality of life: Data from a population-based survey in Germany (SHIP-Trend-0) Neurogastroenterology & Motility 31(3): e13511. doi: 10.1111/nmo.13511.
  27. Dai N, Cong Y & Yuan H (2008) Prevalence of irritable bowel syndrome among undergraduates in Southeast China. Digestive and Liver Disease 40(6): pp 418 - 424.
  28.  Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA et al (2004) A population-based study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling. Alimentary Pharmacology & Therapeutics 19(11): p p 1217– 1224.
  29.  Zhang L, Duan L, Liu Y, Leng Y, Zhang H, Liu Z et al (2014) A meta-analysis of the prevalence of irritable bowel syndrome in Chinese community. Zhonghua nei ke za zhi 53(12): pp 969 – 975.
  30.  Satake R, Sugawara N, Sato K, Takahashi I, Nakaji S, Yasui-Furukori N et al (2015) Prevalence and predictive factors of irritable bowel syndrome in a communitydwelling population in Japan. Internal Medicine 54(24): pp 3105 – 3112.
  31.  Yamamoto R, Kaneita Y, Osaki Y, Kanda H, Suzuki K, Higuchi S et al (2015) Irritable bowel syndrome among Japanese adolescents: a nationally representative survey. Journal of Gastroenterology & Hepatology 30(9): pp1354 – 1360.
  32.  Yun CH, Lee SK, Kim H, Park HK, Lee SH, Kim SJ et al (2012) Association between irritable bowel syndrome and restless legs in the general population. Journal of Sleep Research 21(5): pp 569 – 576.
  33.  Zuckerman MJ, Nguyen G, Ho H, Nguyen L & Gregory GG (2006) A survey of irritable bowel syndrome in Vietnam using the Rome criteria. Digestive Diseases & Sciences 51(5): pp 946- 951.
  34.  K ho sh k r o o d -Ma n s o or i B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A et al (2009) Irritable bowel syndrome: a population based study. Journal of Gastrointestinal and Liver Diseases 18(4): pp 413 – 418.
  35.  Massarrat S, Saberi-Firoozi, A, Himmelmann GW, Hitzges M & Keshavarz H (1995) Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran European Journal of Gastroenterology and Hepatology 7: pp 427 - 433.
  36.  Hoseini-Asl MK & Amra B (2003) Prevalence of irritable bowel syndrome in Shahrekord, Iran Indian Journal of Gastroenterology 22: pp 215 – 216.
  37.  Khademolhosseini F, Mehrabani D, Nejabat M, Beheshti M, Heydari ST, Mirahmadizadeh A et al (2011) Irritable bowel syndrome in adults over 25 years in Shiraz, southern Iran: prevalence and associated factors Journal of Research in Medical Sciences 16: pp 200–206.
  38.  Okeke EN, Ladep NG, Adah S, Bupwatda PW, Agaba EI & Malu AO (2009) Prevalence of irritable bowel syndrome: a community survey in an African population. Annals of African Medicine 8(3): pp 170 -180.
  39.  Madrid-Silva AM, Defilippi-Caffri C, Landskron-Ramos G, Olquín-Herrera F, Reyes-Ponce A, Castro-Lara A et al (2013) The prevalence of irritable bowel syndrome in a population of shopping mall visitors in Santiago de Chile. Revista de Gastroenterologia de Mexico 78(4): pp 203 – 210.
  40.  Álvarez DFG, Vargas JGM, Medina LMAR, Oviedo SCM, López PAC & Jaimes GER (2009) Prevalence of irritable bowel syndrome and associated factors according to Rome lll diagnostic criteria in a general population in Colombia. Gastroenterology & Hepatology 32(6): pp 395 – 400.
  41.  Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G & Muris JW (2011) Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Systematic Reviews Aug 10;(8):CD003460. doi: 10.1002/14651858.CD003460.pub3.
  42.  Rees WD, Evans BK & Rhodes J (1979) Treating irritable bowel syndrome with peppermint oil British Medical Journal 2(194): pp 835 – 836.
  43.  Mosaffa-Jahromi M, Lankarani KB, Pasalar M, Ashfarypuor S & Tamaddon A (2016) Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome. Journal of ethnopharmacology 194: pp 937 - 946.
  44.  Whorwell PJ, Prior A & Faragher EB (1984) Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowelsyndrome. Lancet 2: pp 1232 - 1233.
  45. Radnitz CL & Blanchard EB (1989) A 1- and 2-year follow-up study of bowel sound feedback as a treatment of irritable bowel syndrome. Biofeedback & Self Regulation 14(4): pp 333 - 338.
  46. Goldenberg JZ, Brignall M, Hamilton M, Beardsley J, Batson RD, Hawrelak J et al (2019) . Biofeedback for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews. 2019(11) CD012530. doi: 10.1002/14651858.CD012530.pub2.
  47. Laird KT, Tanner-Smith EE, Russell AC, Hollon SD & Walker LS (2017) Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: a systematic review and meta-analysis. Clinical Psychology Review 51: pp 142 – 152.
  48.  Schumann D, Anhever D, Lauche R, Dobos G, Langhorst J & Cramer H (2016) Effect of yoga in the therapy of irritable bowel syndrome: a systematic review. Clinical Gastroenterology & Hepatology 14(12): pp1720 - 1731.
  49.  Ghandi F, Sadeghi A, Bakhtyari M, Imani S, Abdi S & Banihashem SS (2018) Comparing the efficacy of mindfulness-based stress reduction therapy with emotion regulation treatment on quality of life and symptoms of irritable bowel syndrome. Iranian Journal of Psychiatry 13(3): pp 175 – 183.